Image Number 13 for United States Patent #8128929.
The invention provides antibodies that bind to human PDGFR.alpha. and neutralize activation of the receptor. The invention further provides methods for neutralizing activation of PDGFR.alpha. and methods of treating a mammal with a neoplastic disease using the antibodies alone or in combination with other agents.